References

Alexandrou E, Ray-Barruel G, Carr PJ International prevalence of the use of peripheral intravenous catheters. J Hosp Med. 2015; 10:(8)530-533 https://doi.org/10.1002/jhm.2389

Alexandrou E, Ray-Barruel G, Carr PJ Use of short peripheral intravenous catheters: characteristics, management, and outcomes worldwide. J Hosp Med. 2018; 13:(5) https://doi.org/10.12788/jhm.3039

Barton A. Clinical use of closed-system safety peripheral intravenous cannulas. Br J Nurs. 2018; 27:(8)S22-S27 https://doi.org/10.12968/bjon.2018.27.8.S22

Bitmead J, Oliver G. A safe procedure: best practice for intravenous peripheral cannulation. Br J Nurs. 2018; 27:S1-S8 https://doi.org/10.12968/bjon.2018.27.Sup2.S1

Blanco-Mavillard I, Rodríguez-Calero MÁ, de Pedro-Gómez J, Parra-García G, Fernández-Fernández I, Castro-Sánchez E. Incidence of peripheral intravenous catheter failure among inpatients: variability between microbiological data and clinical signs and symptoms. Antimicrob Resist Infect Control. 2019; 22;8 https://doi.org/10.1186/s13756-019-0581-8

UK Sepsis Trust. The sepsis manual. 2022. https//sepsistrust.org/wp-content/uploads/2022/06/Sepsis-Manual-Sixth-Edition.pdf (accessed 17 July 2023)

Dougherty L. Peripheral cannulation. Nurs Stand. 2008; 22:(52)49-56 https://doi.org/10.7748/ns2009.04.23.33.59.c7187

Forsyth JM, Shalan A, Thompson AR. Venous access made easy, 1st edn. New York (NY): CRC Press. Taylor & Francis Group; 2019

Peripheral venous access in adults. 2023. https//www.uptodate.com/contents/peripheral-venous-access-in-adults (accessed 17 July 2023)

Gorski LA, Hadaway L, Hagle ME Infusion Therapy Standards of Practice. J Infus Nurs. 2021; 44:(1S)S1-S224 https://doi.org/10.1097/NAN.0000000000000396

Hallam C, Denton A, Weston V UK Vessel Health and Preservation (VHP) Framework: a commentary on the updated VHP 2020. J Infect Prev. 1721; 22:(4)147-155 https://doi.org/10.1177/1757177420976806

Helm RE. Accepted but unacceptable. J Infus Nurs. 2019; 42:(3)149-150 https://doi.org/10.1097/NAN.0000000000000324

Jackson T, Hallam C, Corner T, Hill S. Right line, right patient, right time: every choice matters. Br J Nurs. 2013; 22:S24-S28 https://doi.org/10.12968/bjon.2013.22.Sup5.S24

, 10th edn. In: Lister S, Hofland J, Grafton H, Wilson C (eds). Chichester: Wiley-Blackwell; 2021

Marsh N, Mihala G, Ray-Barruel G, Webster J, Wallis MC, Rickard CM. Inter-rater agreement on PIVC-associated phlebitis signs, symptoms and scales. J Eval Clin Pract. 2015; 21:(5)893-899 https://doi.org/10.1111/jep.12396

Medusa Injectable Medicines Guide. 2023. https//www.medusaimg.nhs.uk (accessed June 2023)

Mörgeli R, Schmidt K, Neumann T A comparison of first-attempt cannulation success of peripheral venous catheter systems with and without wings and injection ports in surgical patients—a randomized trial. BMC Anesthesiol. 2022; 22:(1) https://doi.org/10.1186/s12871-022-01631-7

Munoz-Mozas G, Hyde L, Overland H. Vascular access devices: insertion and management Chapter 17, 10th edn. In: Lister S, Hofland J, Grafton H, Wilson C (eds). Chichester: Wiley-Blackwell; 2021

Munoz-Mozas G. Solving the problem of IV dislodgement. Br J Nurs. 2022; 31:(2)S4-S7 https://doi.org/10.12968/bjon.2022.31.2.S4

National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. Clinical guideline [CG174]. 2017. https//www.nice.org.uk/guidance/cg174 (accessed 17 July 2023)

NHS Clinical Evaluation Team. Clinical review. Safety peripheral intravenous cannula. 2018. https//tinyurl.com/3r3bdpm5 (accessed 17 July 2023)

NHS Scotland. Good practice statement for the preperation of injections in near-patient areas, including clinical and home environments (archived). 2002. https//webarchive.nrscotland.gov.uk/3000mp_/ (accessed 17 July 2023)

Royal College of Nursing. Standards for infusion therapy. (Under review, use with caution.). 2016. https//tinyurl.com/3fsfrtuc (accessed 17 July 2023)

National Early Warning Score (NEWS): standardising the assessment of acute-illness severity in the NHS.London: RCP; 2012

Stanley AK, Barnett-Vanes A, Reed MJ. Peripheral intravenous cannula usage in the emergency department. Emergency Care Journal. 2020; 16:(3) https://doi.org/10.4081/ecj.2020.9205

Weinstein S, Hagle ME. Plumer's principles & practice of infusion therapy, 9th edn. Philadelphia (PA): Lippincott Williams & Wilkins; 2014

Zhang L, Cao S, Marsh N Infection risks associated with peripheral vascular catheters. J Infect Prev. 2016; 17:(5)207-213 https://doi.org/10.1177/1757177416655472

A safe and effective winged peripheral intravenous cannula for use in clinical practice

25 January 2024
Volume 33 · Issue 2

Abstract

Vascular access continues to be a key factor for the reliable and safe delivery of intravenous (IV) therapy to patients in any healthcare setting. Clinical guidelines advocate for the right vascular access device selection, in order to reduce avoidable complications, eg multiple stabs, phlebitis, thrombophlebitis, insertion site infection, and blood stream infection, while improving efficiency and reducing costs. Peripheral intravenous catheters or cannulas (PIVCs) remain widely used for gaining vascular access in all clinical settings, with both adults and children, because they provide a relatively cheap and simple way to provide blood sampling and the prompt administration of IV medications. Although safe and easy to insert, PIVCs present with associated risks that can be costly to the organisation. The case studies included with this article introduce Nipro's Safetouch Cath Winged with Injection Port as a new cost-effective choice of PIVC, which is now available from NHS Supply Chain.

Many patients admitted to hospital or receiving care in other settings, including home care, will receive intravenous (IV) therapy at some point (NHS Scotland, 2002; Royal College of Nursing (RCN), 2016; National Institute for Health and Care Excellence (NICE), 2017). These patients will require the insertion of a peripheral intravenous catheter or cannula (PIVC), or a central venous access device (CVAD) to facilitate the delivery of treatment.

An audit of 14 hospitals across 13 countries prompted Alexandrou et al (2015) to estimate that in 2015, globally, there were over 1 billion PIVC insertions. A subsequent international study by Alexandrou et al (2018) estimated that the majority of hospitalised patients worldwide would have at least one PIVC in place. In the case of the UK, Zhang et al (2016) determined that 1 in 3 patients would have at least one PIVC in situ. The NHS spends an estimated £29 million of its annual acute sector budget on PIVC procurement, with at least 25 million devices sold annually in the UK (NHS Clinical Evaluation Team, 2018; Stanley et al, 2020).

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content